I had a look in detail at these new scanners since you seemed very assured of them based off one Ann by telix flotsam.
im unsure why you're so convinced that these new scanners will level the playing field? Reading up about the uExplorer, the main thing it does it increases the sensitivity of resolution for less radiation. Another major selling point is that it effectively decreases time of scan from 40m to 10m.
None of the Ann that I looked through has actually said that it'll make all diagnostic agents pick up lesions that it may not have had uptake in the lesion. It may allow a lesion be picked up due to the ability to decrease the noise around signal and allow for better resolution. However, if the smaller lesions ie <4mm lesions don't have uptake from F18/GA68, it doesn't mean these new scanners will show the avidity of it. All it does is increase the resolution of the scanner. This means cu64 is still better irrespective of scanner tech.
- Forums
- ASX - By Stock
- CU6
- Ann: Head-to-head IIT with SAR-bisPSMA
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
5.44%
!
$2.52

Ann: Head-to-head IIT with SAR-bisPSMA, page-66
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.52 |
Change
0.130(5.44%) |
Mkt cap ! $810.1M |
Open | High | Low | Value | Volume |
$2.39 | $2.54 | $2.37 | $5.141M | 2.072M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6820 | $2.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.52 | 3500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 405 | 2.500 |
1 | 20000 | 2.480 |
4 | 41204 | 2.450 |
1 | 5000 | 2.410 |
5 | 3695 | 2.400 |
Price($) | Vol. | No. |
---|---|---|
2.520 | 3500 | 1 |
2.540 | 37102 | 3 |
2.550 | 30520 | 6 |
2.580 | 30000 | 2 |
2.590 | 10004 | 2 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online